U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944132) titled 'CsA vs MMC for Preventing Pterygium Recurrence' on April 11.
Brief Summary: aimed to compare the efficacy and safety of topical cyclosporin A (CsA) versus mitomycin C (MMC) as adjunctive therapies in preventing pterygium recurrence after surgical excision.
Study Start Date: April 01, 2024
Study Type: INTERVENTIONAL
Condition:
Pterygium
Pterygium of the Conjunctiva and Cornea
Intervention:
PROCEDURE: Excision of the pterygium
The surgical procedure involved excision of the pterygium, including the fibrovascular head and associated conjunctival tissue, followed by bare sclera closure using an autologous conjunctival graft harv...